27249024|t|Association of Metabolites with Obesity and Type 2 Diabetes Based on FTO Genotype
27249024|a|The single nucleotide polymorphism rs9939609 of the gene FTO, which encodes fat mass and obesity -associated protein, is strongly associated with obesity and type 2 diabetes (T2D) in multiple populations; however, the underlying mechanism of this association is unclear. The present study aimed to investigate FTO genotype -dependent metabolic changes in obesity and T2D. To elucidate metabolic dysregulation associated with disease risk genotype, genomic and metabolomic datasets were recruited from 2,577 participants of the Korean Association REsource (KARE) cohort, including 40 homozygous carriers of the FTO risk allele (AA), 570 heterozygous carriers (AT), and 1,967 participants carrying no risk allele (TT). A total of 134 serum metabolites were quantified using a targeted metabolomics approach. Through comparison of various statistical methods, seven metabolites were identified that are significantly altered in obesity and T2D based on the FTO risk allele (adjusted p < 0.05). These identified metabolites are relevant to phosphatidylcholine metabolic pathway, and previously reported to be metabolic markers of obesity and T2D. In conclusion, using metabolomics with the information from genome-wide association studies revealed significantly altered metabolites depending on the FTO genotype in complex disorders. This study may contribute to a better understanding of the biological mechanisms linking obesity and T2D.
27249024	15	26	Metabolites	T123	C0870883
27249024	32	39	Obesity	T047	C0028754
27249024	44	59	Type 2 Diabetes	T047	C0011860
27249024	69	72	FTO	T028	C1970415
27249024	73	81	Genotype	T032	C0017431
27249024	86	116	single nucleotide polymorphism	T086	C0752046
27249024	117	142	rs9939609 of the gene FTO	T028	C1970415
27249024	158	166	fat mass	T032	C3656665
27249024	171	178	obesity	T047	C0028754
27249024	191	198	protein	T116,T123	C0033684
27249024	228	235	obesity	T047	C0028754
27249024	240	255	type 2 diabetes	T047	C0011860
27249024	257	260	T2D	T047	C0011860
27249024	274	285	populations	T098	C1257890
27249024	365	370	study	T062	C2603343
27249024	392	395	FTO	T028	C1970415
27249024	396	404	genotype	T032	C0017431
27249024	416	425	metabolic	T040	C0025519
27249024	426	433	changes	T169	C0392747
27249024	437	444	obesity	T047	C0028754
27249024	449	452	T2D	T047	C0011860
27249024	467	490	metabolic dysregulation	T046	C2362507
27249024	507	519	disease risk	T201	C0012655
27249024	520	528	genotype	T032	C0017431
27249024	530	537	genomic	T170	C0150098
27249024	542	562	metabolomic datasets	T170	C0150098
27249024	589	601	participants	T098	C0679646
27249024	609	650	Korean Association REsource (KARE) cohort	T098	C0599755
27249024	665	675	homozygous	T032	C0019904
27249024	676	684	carriers	T033	C0007294
27249024	692	695	FTO	T028	C1970415
27249024	701	712	allele (AA)	T028	C0002085
27249024	718	730	heterozygous	T032	C0019425
27249024	731	739	carriers	T033	C0007294
27249024	756	768	participants	T098	C0679646
27249024	786	797	allele (TT)	T028	C0002085
27249024	814	819	serum	T031	C0229671
27249024	820	831	metabolites	T123	C0870883
27249024	865	877	metabolomics	T091	C1328813
27249024	918	937	statistical methods	T062	C1710191
27249024	945	956	metabolites	T123	C0870883
27249024	1007	1014	obesity	T047	C0028754
27249024	1019	1022	T2D	T047	C0011860
27249024	1036	1039	FTO	T028	C1970415
27249024	1045	1051	allele	T028	C0002085
27249024	1090	1101	metabolites	T123	C0870883
27249024	1118	1137	phosphatidylcholine	T109,T121,T123	C1959616
27249024	1138	1155	metabolic pathway	T169	C1291081
27249024	1187	1204	metabolic markers	T123	C1513159
27249024	1208	1215	obesity	T047	C0028754
27249024	1220	1223	T2D	T047	C0011860
27249024	1246	1258	metabolomics	T091	C1328813
27249024	1285	1316	genome-wide association studies	T063	C2350277
27249024	1348	1359	metabolites	T123	C0870883
27249024	1377	1380	FTO	T028	C1970415
27249024	1381	1389	genotype	T032	C0017431
27249024	1417	1422	study	T062	C2603343
27249024	1501	1508	obesity	T047	C0028754
27249024	1513	1516	T2D	T047	C0011860